|
|
|
Insider
Information: |
Gryska David W |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
178,351 |
|
Indirect Shares
|
750 |
|
|
Direct
Value |
$1,034,542 |
|
|
Indirect Value
|
$81,180 |
|
|
Total
Shares |
179,101 |
|
|
Total
Value |
$1,115,722 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
1.0
|
Percentage
Gain/Loss : |
-100.0%
|
45.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2006-02-14 |
0 |
Premium* |
|
Celgene Corp |
CELG |
Chief Financial Officer |
2010-05-04 |
864 |
2010-05-04 |
750 |
Premium* |
|
PDL Biopharma Inc |
PDLI |
Director |
2020-12-30 |
1,387 |
2014-03-06 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Executive Vice Preside... |
2018-07-16 |
10,235 |
2015-01-08 |
0 |
Premium* |
|
Aerie Pharmaceuticals Inc |
AERI |
Director |
2022-11-21 |
0 |
2022-11-21 |
0 |
Premium* |
|
Mind Medicine |
MNMD |
|
2024-08-23 |
17,351 |
2023-06-21 |
0 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
Director |
2023-07-31 |
148,514 |
2023-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Executive Vice President, CFO |
|
2017-11-01 |
4 |
D |
$107.96 |
$422,447 |
D/D |
(3,913) |
17,907 |
0 |
- |
|
INCY |
Incyte Corp |
Executive Vice President, CFO |
|
2017-11-02 |
4 |
AS |
$105.63 |
$413,541 |
D/D |
(3,915) |
13,992 |
0 |
- |
|
INCY |
Incyte Corp |
Executive Vice President, CFO |
|
2018-01-05 |
4 |
AS |
$98.87 |
$668,361 |
D/D |
(6,760) |
13,992 |
0 |
- |
|
INCY |
Incyte Corp |
Executive Vice President, CFO |
|
2018-01-05 |
4 |
OE |
$83.83 |
$566,691 |
D/D |
6,760 |
20,752 |
0 |
- |
|
INCY |
Incyte Corp |
Executive Vice President, CFO |
|
2018-02-20 |
4 |
D |
$86.03 |
$92,052 |
D/D |
(1,070) |
12,922 |
0 |
- |
|
INCY |
Incyte Corp |
Executive Vice President, CFO |
|
2018-02-21 |
4 |
AS |
$85.56 |
$167,013 |
D/D |
(1,952) |
10,970 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2018-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
45,050 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Director |
|
2018-06-08 |
4 |
A |
$2.76 |
$150,000 |
D/D |
54,348 |
219,511 |
0 |
- |
|
INCY |
Incyte Corp |
Executive Vice President, CFO |
|
2018-07-05 |
4 |
D |
$68.28 |
$19,118 |
D/D |
(280) |
10,690 |
0 |
- |
|
INCY |
Incyte Corp |
Executive Vice President, CFO |
|
2018-07-16 |
4 |
D |
$70.19 |
$31,936 |
D/D |
(455) |
10,235 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-01-08 |
4 |
AS |
$65.04 |
$325,200 |
D/D |
(5,000) |
45,050 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-01-08 |
4 |
OE |
$12.76 |
$63,800 |
D/D |
5,000 |
50,050 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-04-01 |
4 |
OE |
$12.76 |
$63,800 |
D/D |
5,000 |
50,050 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-04-01 |
4 |
AS |
$73.38 |
$367,030 |
D/D |
(5,000) |
45,050 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
48,013 |
0 |
- |
|
AERI |
Aerie Pharmaceuticals Inc |
Director |
|
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-07-17 |
4 |
AS |
$75.00 |
$375,000 |
D/D |
(5,000) |
48,013 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-07-17 |
4 |
OE |
$12.76 |
$63,800 |
D/D |
5,000 |
53,013 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-10-01 |
4 |
OE |
$12.76 |
$79,450 |
D/D |
5,000 |
50,513 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2019-10-01 |
4 |
AS |
$84.85 |
$425,450 |
D/D |
(5,000) |
48,013 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,335 |
49,348 |
0 |
- |
|
AERI |
Aerie Pharmaceuticals Inc |
Director |
|
2020-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
3,500 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Director |
|
2020-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,826 |
245,337 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2020-11-05 |
4 |
S |
$180.60 |
$812,699 |
D/D |
(4,500) |
44,848 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Director |
|
2020-11-17 |
4 |
S |
$2.40 |
$240,000 |
D/D |
(100,000) |
145,337 |
0 |
- |
|
105 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|